Related Experiment Videos
Cell surface molecules and their prognostic values in assessing colorectal carcinomas
J Haier1, M Nasralla, G L Nicolson
1The Institute for Molecular Medicine, Huntington Beach, California 92649-10941, USA.
Annals of Surgery
|January 15, 2000
Summary
Identifying prognostic cell surface markers in colorectal cancer is crucial for improving patient outcomes. Standardized multivariate analysis is needed to validate these markers for effective adjuvant therapy in Dukes B and C stages.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer is a leading cause of cancer death.
- Advances in surgery improve early-stage survival, but advanced stages show limited improvement.
- Patient subgroup selection may enhance adjuvant therapy effectiveness for Dukes B and C carcinomas.
Purpose of the Study:
- To review data on cell surface molecules as prognostic markers for colorectal carcinomas.
- To evaluate the statistical analysis and multivariate procedures used in identifying prognostic factors.
Main Methods:
- Literature review of available data.
- Focus on statistical analysis and multivariate procedures.
- Identification of cell surface molecules related to colorectal cancer prognosis.
Main Results:
- Several cell surface molecules (adhesion molecules, growth factor receptors, proteinases) are linked to colorectal cancer progression and prognosis.
- These molecules show potential as prognostic markers.
Conclusions:
- Data on prognostic cell surface markers exist, but multivariate analysis is underutilized.
- New tumor markers require rigorous validation using standardized multivariate analysis for clinical relevance in colorectal cancer management.